Study of CAR.70-engineered IL15-transduced Cord Blood-derived NK Cells in Conjunction With Lymphodepleting Chemotherapy for the Management of Advanced Renal Cell Carcinoma, Mesothelioma and Osteosarcoma

Conditions:   Advanced Renal Cell Carcinoma;   Advanced Mesothelioma;   Advanced Osteosarcoma Interventions:   Drug: CAR.70/IL15-transduced CB-derived NK cells;   Drug: Fludarabine phosphate;   Drug: Cyclophosphamide Sponsor:   M.D. Anderson Cancer Center Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials